These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 26317978

  • 1. The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection.
    Dalgard O, Martinot-Peignoux M, Verbaan H, Bjøro K, Ring-Larsen H, Marcellin P.
    PLoS One; 2015; 10(8):e0120866. PubMed ID: 26317978
    [Abstract] [Full Text] [Related]

  • 2. Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients.
    Baleriola C, Rawlinson WD, Dore GJ, Chaverot S, Stelzer-Braid S, Yoshihara M, Crawford D, Sievert W, McCaughan G, Weltman M, Cheng W, Rizkalla B, Dubois D, Thommes J, Roberts S.
    Antivir Ther; 2011; 16(2):173-80. PubMed ID: 21447866
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.
    Martinot-Peignoux M, Stern C, Maylin S, Ripault MP, Boyer N, Leclere L, Castelnau C, Giuily N, El Ray A, Cardoso AC, Moucari R, Asselah T, Marcellin P.
    Hepatology; 2010 Apr; 51(4):1122-6. PubMed ID: 20069649
    [Abstract] [Full Text] [Related]

  • 5. HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
    Morishima C, Morgan TR, Everhart JE, Wright EC, Shiffman ML, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Gretch DR, HALT-C Trial Group.
    Hepatology; 2006 Aug; 44(2):360-7. PubMed ID: 16871570
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Real-time PCR assays for hepatitis C virus RNA (genotype 1) is useful for evaluating virological response to the treatment with peginterferon-alpha2b and ribavirin.
    Nakaya M, Enomoto M, Fujii H, Kobayashi S, Iwai S, Morikawa H, Tamori A, Sakaguchi H, Kawada N.
    Osaka City Med J; 2013 Dec; 59(2):79-89. PubMed ID: 24575583
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection.
    Vermehren J, Aghemo A, Falconer K, Susser S, Lunghi G, Zeuzem S, Colombo M, Weiland O, Sarrazin C.
    J Hepatol; 2014 May; 60(5):913-9. PubMed ID: 24424305
    [Abstract] [Full Text] [Related]

  • 10. Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infection.
    Halfon P, Pénaranda G, Bourlière M, Khiri H, Masseyeff MF, Ouzan D.
    J Med Virol; 2006 Feb; 78(2):208-15. PubMed ID: 16372298
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunological and mutagenic actions of ribavirin monotherapy preceding combination therapy with interferon for patients with chronic hepatitis C.
    Ogawa K, Hige S, Nakanishi M, Yamamoto Y, Chuma M, Nagasaka A, Asaka M.
    Antivir Ther; 2009 Feb; 14(4):513-22. PubMed ID: 19578236
    [Abstract] [Full Text] [Related]

  • 18. Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapy.
    Knop V, Teuber G, Klinker H, Möller B, Rasenack J, Hinrichsen H, Gerlach T, Spengler U, Buggisch P, Neumann K, Sarrazin C, Zeuzem S, Berg T.
    Ann Hepatol; 2013 Feb; 12(2):190-8. PubMed ID: 23396729
    [Abstract] [Full Text] [Related]

  • 19. Viral kinetics of hepatitis C virus RNA in patients with chronic hepatitis C treated with 18 MU of interferon alpha daily.
    Sentjens RE, Weegink CJ, Beld MG, Cooreman MC, Reesink HW.
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):833-40. PubMed ID: 12172402
    [Abstract] [Full Text] [Related]

  • 20. Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir.
    Maasoumy B, Cobb B, Bremer B, Luk K, Halfon P, Aslam S, Manns MP, Cornberg M, Wedemeyer H.
    Aliment Pharmacol Ther; 2014 Jan; 39(1):85-92. PubMed ID: 24206524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.